Gene · 4738
Papers3,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia? | J Clin Med | 2024 | 38256681 | PubTator, text mining | PubMed |
| SMC5/6 Promotes Replication Fork Stability via Negative Regulation of the COP9 Signalosome. | Int J Mol Sci | 2024 | 38256025 | PubTator, text mining | PubMed |
| The CUL5 E3 ligase complex negatively regulates central signaling pathways in CD8+ T cells. | Nat Commun | 2024 | 38242867 | PubTator, text mining | PubMed |
| Tribbles pseudokinase 3 promotes enterovirus A71 infection via dual mechanisms. | Emerg Microbes Infect | 2024 | 38240287 | PubTator, text mining | PubMed |
| Neddylation is a novel therapeutic target for lupus by regulating double negative T cell homeostasis. | Signal Transduct Target Ther | 2024 | 38221551 | PubTator, text mining | PubMed |
| Diabetic sensory neuropathy and insulin resistance are induced by loss of UCHL1 in Drosophila. | Nat Commun | 2024 | 38212312 | PubTator, text mining | PubMed |
| Emerging role of NEDD8-mediated neddylation in age-related metabolic diseases. | Ageing Res Rev | 2024 | 38199526 | PubTator, text mining | PubMed |
| Deciphering the role of neddylation in tumor microenvironment modulation: common outcome of multiple signaling pathways. | Biomark Res | 2024 | 38191508 | PubTator, text mining | PubMed |
| Vemurafenib induces senescence in acute myeloid leukemia and myelodysplastic syndrome by activating the HIPPO signaling pathway: implications for potential targeted therapy. | Biol Direct | 2024 | 38178263 | PubTator, text mining | PubMed |
| DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. | Nat Commun | 2024 | 38177131 | PubTator, text mining | PubMed |
| Cullin5 drives experimental asthma exacerbations by modulating alveolar macrophage antiviral immunity. | Nat Commun | 2024 | 38177117 | PubTator, text mining | PubMed |
| Targeting NEDD8 suppresses surgical stress-facilitated metastasis of colon cancer via restraining regulatory T cells. | Cell Death Dis | 2024 | 38177106 | PubTator, text mining | PubMed |
| TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | Nat Commun | 2024 | 38172120 | PubTator, text mining | PubMed |
| The structural basis for deubiquitination by the fingerless USP-type effector TssM. | Life Sci Alliance | 2024 | 38170641 | PubTator, text mining | PubMed |
| TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis. | J Transl Med | 2024 | 38167440 | PubTator, text mining | PubMed |
| Crystal structure of bacterial ubiquitin ADP-ribosyltransferase CteC reveals a substrate-recruiting insertion. | J Biol Chem | 2024 | 38159861 | PubTator, text mining | PubMed |
| Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma. | Blood | 2024 | 38142436 | PubTator, text mining | PubMed |
| NNMT/1-MNA Promote Cell-Cycle Progression of Breast Cancer by Targeting UBC12/Cullin-1-Mediated Degradation of P27 Proteins. | Adv Sci (Weinh) | 2024 | 38126621 | PubTator, text mining | PubMed |
| Proteotoxic stress and the ubiquitin proteasome system. | Semin Cell Dev Biol | 2024 | 37734998 | PubTator, text mining | PubMed |
| TGF-β Score based on Silico Analysis can Robustly Predict Prognosis and Immunological Characteristics in Lower-grade Glioma: The Evidence from Multicenter Studies. | Recent Pat Anticancer Drug Discov | 2024 | 37718518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4738/papers?page=10